Browsing by Author Mahon, Kate

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 10 of 10
Issue DateTitleAuthor(s)Citation
2014Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancerBoyer, Michael; Gurney, Howard; Horvath, Lisa; Mahon, Kate; Marx, Gavin; Pavlakis, Nick; Stockler, Martin; Castillo, Lesley; Chiam, K; Clark, Susan J.; Daly, R; Lee, B Y; Lin, H-M; Mallesara, G; Nguyen, Q; Swarbrick, A.; Central Clinical School: Medicine; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; School of Public Health: Public Health; Medicine; Northern Clinical School: Medicine; School of Public Health: NH&MRC Clinical Trials CentreCirculating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer, British Journal of Cancer, vol.110, 10, 2014,pp 2462-2471
2015Cytokine profiling of docetaxel-resistant castration-resistant prostate cancerBoyer, Michael; Horvath, Lisa; Mahon, Kate; Marx, Gavin; Pavlakis, Nick; Stockler, Martin; Breit, Samuel; Brown, David; Castillo, Lesley; Chatfield, Mark; Chiam, K; Daly, R; Henshall, Susan; Lee, B Y; Lee-Ng, K K Michelle; Lin, H-M; Molloy, Mark; Central Clinical School: Medicine; Central Clinical School: Medicine; School of Public Health: Public Health; Medicine; Northern Clinical School: Medicine; NH&MRC Clinical Trials CentreCytokine profiling of docetaxel-resistant castration-resistant prostate cancer, British Journal of Cancer, vol.112, 8, 2015,pp 1340-1348
2017A distinct plasma lipid signature associated with poor prognosis in castration-resistant prostate cancerGurney, Howard; Horvath, Lisa; Hoy, Andrew; Marx, Gavin; Stockler, Martin; Briscoe, Karen; Daly, Roger; Lin, Hui-Ming; Mahon, Kate; Mallesara, Girish; Meikle, Peter; Mundra, Piyushkumar; Parton, Robert G.; Spielman, Calan; Weir, Jacquelyn; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; School of Medical Sciences: Physiology; SAHCS: Medicine; NH&MRC Clinical Trials CentreA distinct plasma lipid signature associated with poor prognosis in castration-resistant prostate cancer, International Journal of Cancer, vol.141, 10, 2017,pp 2112-2120
2016Loss of AZGP1 as a Superior Predictor of Relapse in Margin-Positive Localized Prostate CancerGupta, Ruta; Horvath, Lisa; Kench, James; Mahon, Kate; Bruce, Hannah; Haynes, Anne Marie; Lin, Hui-Ming; Savdie, Richard; Stricker, Phillip D; School of Medical Sciences: Pathology; Central Clinical School: Medicine; School of Medical Sciences: Pathology; School of Public Health: Public HealthLoss of AZGP1 as a Superior Predictor of Relapse in Margin-Positive Localized Prostate Cancer, The Prostate, vol.76, 16, 2016,pp 1491-1500
2016Loss of AZGP1 as a Superior Predictor of Relapse in Margin-Positive Localized Prostate CancerGupta, Ruta; Horvath, Lisa; Kench, James; Mahon, Kate; Bruce, Hannah; Haynes, Anne Marie; Lin, Hui-Ming; Savdie, Richard; Stricker, Phillip D; School of Medical Sciences: Pathology; Central Clinical School: Medicine; School of Medical Sciences: Pathology; School of Public Health: Public HealthLoss of AZGP1 as a Superior Predictor of Relapse in Margin-Positive Localized Prostate Cancer, The Prostate, vol.76, 16, 2016,pp 1491-1500
2014Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancerBoyer, Michael; Gurney, Howard; Horvath, Lisa; Mahon, Kate; Marx, Gavin; Stockler, Martin; Castillo, Lesley; Chatfield, Mark; Clark, Susan J.; Devaney, James; Mallesara, G; Molloy, Peter; Paul, Cheryl; Qu, W; Wykes, R J; Central Clinical School: Medicine; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; School of Public Health: Public Health; Medicine; School of Public Health: NH&MRC Clinical Trials CentreMethylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer, British Journal of Cancer, vol.111, 9, 2014,pp 1802-1809
2011Pathways of chemotherapy resistance in castration-resistant prostate cancerHorvath, Lisa; Mahon, Kate; Henshall, Susan M.; Sutherland, Robert L.; Central Clinical School: Medicine; School of Public Health: Public HealthPathways of chemotherapy resistance in castration-resistant prostate cancer, Endocrine-Related Cancer, vol.18, 4, 2011,pp R103-R123
2017Phase 2 study of circulating microRNA biomarkers in castration-resistant prostate cancerHorvath, Lisa; Marx, Gavin; Stockler, Martin; Bastick, Patricia; Briscoe, Karen; Gurney, H; Lin, H; Mahon, Kate; Mallesara, Girish; Spielman, Calan; Swarbrick, A; Central Clinical School: Medicine; SAHCS: Medicine; NH&MRC Clinical Trials CentrePhase 2 study of circulating microRNA biomarkers in castration-resistant prostate cancer, British Journal of Cancer, vol.116, 8, 2017,pp 1002-1011
2012Remarkable temporal stability of high-abundance human plasma proteins assessed by targeted mass spectrometryClarke, Stephen; Horvath, Lisa; Mahon, Kate; McKay, Matthew; Molloy, Mark; Pascovici, Dana; Randall, Sarah; Concord Clinical School: Medicine; Central Clinical School: MedicineRemarkable temporal stability of high-abundance human plasma proteins assessed by targeted mass spectrometry, Proteomics - Clinical Applications, vol.6, 11-12, 2012,pp 626-634
2017Somatic mutations in salivary duct carcinoma and potential therapeutic targetsBoyer, Michael; Clark, Jonathan; Clarke, Angus; Gupta, Ruta; Khoo, Timothy; Mahon, Kate; O'Toole, Sandra; Palme, Carsten Erich; Yu, Bing; Cowley, Mark J.; Dinger, Marcel; Kraitsek, Spiridoula; Luk, Peter P.; Selinger, Christina; Smith, Joel A.; Central Clinical School: Medicine; Central Clinical School: Surgery; Central Clinical School: Medicine; Central Clinical School: Pathology; Central Clinical School: Medicine; School of Public Health: Public Health; Central Clinical School: Pathology; Western Clinical School: Surgery; Central Clinical School: MedicineSomatic mutations in salivary duct carcinoma and potential therapeutic targets, Oncotarget, vol.8, 44, 2017,pp 75893-75903